Endovascular Thrombectomy Outcomes with and without Intravenous Thrombolysis for Large Ischemic Cores Identified with CT or MRI

医学 溶栓 改良兰金量表 脑出血 冲程(发动机) 优势比 血管内治疗 脑梗塞 回顾性队列研究 内科学 外科 缺血性中风 缺血 心肌梗塞 蛛网膜下腔出血 动脉瘤 工程类 机械工程
作者
Imad Derraz,Solène Moulin,Benjamin Gory,Maéva Kyheng,Caroline Arquizan,Vincent Costalat,Bertrand Lapergue
出处
期刊:Radiology [Radiological Society of North America]
卷期号:309 (1) 被引量:12
标识
DOI:10.1148/radiol.230440
摘要

Background Whether intravenous thrombolysis (IVT) prior to endovascular thrombectomy (EVT) provides additional benefits in patients with acute ischemic stroke (AIS) and a large infarct core (LIC) remains unclear. Purpose To examine whether treatment with IVT before EVT is beneficial in patients with LIC identified with CT or MRI (Alberta Stroke Program Early CT score 0-5). Materials and Methods This retrospective study included consecutive adult patients diagnosed with AIS due to large vessel occlusion (LVO) and LIC treated with EVT who were enrolled in the ETIS (Endovascular Treatment in Ischemic Stroke) Registry in France between January 2015 and January 2022. The primary outcome measure was a favorable outcome (modified Rankin Scale [mRS] score 0-3) at 90 days. Secondary outcomes included functional independence (mRS score 0-2) at 90 days, improvement in degree of disability (ordinal shift in mRS score toward a better outcome) at 90 days, early neurologic improvement at 24 hours, and successful reperfusion (modified Thrombolysis in Cerebral Infarction score of 2b or higher). Safety outcomes included symptomatic intracerebral hemorrhage within 24 hours and mortality at 90 days. Inverse probability of treatment weighting (IPTW)-adjusted analysis was used to assess the treatment effect of IVT adjusted for baseline variables. Results Of 1408 patients (mean age, 68.3 years ± 15.4 [SD]; 789 men), 654 (46.4%) were treated with IVT prior to EVT. In the IPTW-adjusted data set, IVT plus EVT was associated with a higher rate of favorable outcome at 90 days (odds ratio [OR], 1.24 [95% CI: 1.05, 1.46]; P = .01), functional independence at 90 days (OR, 1.47 [95% CI: 1.22, 1.77]; P < .001), improvement in degree of disability at 90 days (common OR, 1.30 [95% CI: 1.13, 1.49]; P < .001), early neurologic improvement (OR, 1.26 [95% CI: 1.07, 1.49]; P = .005), and successful reperfusion (OR, 1.43 [95% CI: 1.14, 1.79]; P = .002) than EVT alone. Rates of brain hemorrhage within 24 hours and mortality at 90 days were similar between groups. Conclusion In patients with AIS due to LVO with LIC identified with CT or MRI, treatment with IVT before EVT appeared to provide a clinical benefit over EVT alone. Clinical trial registration no. NCT03776877 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Kallmes and Rabinstein in this issue.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wangchangli发布了新的文献求助10
刚刚
李珂完成签到,获得积分10
1秒前
门捷列夫完成签到,获得积分10
1秒前
小呆鹿完成签到,获得积分10
1秒前
Sherlock完成签到,获得积分10
1秒前
2秒前
地瓜儿完成签到,获得积分10
2秒前
zhangyidian应助living笑白采纳,获得10
3秒前
LL发布了新的文献求助10
3秒前
3秒前
3秒前
清图完成签到,获得积分10
4秒前
wu发布了新的文献求助10
4秒前
jychen85完成签到 ,获得积分0
4秒前
未来掌管论文的神完成签到,获得积分10
4秒前
绿色催化完成签到,获得积分10
4秒前
5秒前
5秒前
量子星尘发布了新的文献求助10
5秒前
上官子默完成签到,获得积分10
6秒前
不安一鸣完成签到,获得积分10
6秒前
6秒前
柯续缘完成签到,获得积分10
7秒前
科研通AI5应助辉hui采纳,获得10
7秒前
7秒前
Frank发布了新的文献求助10
7秒前
CipherSage应助科研r采纳,获得10
8秒前
8秒前
鑫渊完成签到,获得积分10
9秒前
9秒前
笑点低胡萝卜完成签到,获得积分10
9秒前
有何丿不可给18166992885的求助进行了留言
10秒前
丘比特应助无奈沛白采纳,获得10
10秒前
kkk完成签到,获得积分10
10秒前
10秒前
11秒前
11秒前
Jasper应助hs采纳,获得10
11秒前
柔弱嵩完成签到,获得积分10
11秒前
Zpiao完成签到,获得积分20
12秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
Statistical Methods for the Social Sciences, Global Edition, 6th edition 600
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
The Insulin Resistance Epidemic: Uncovering the Root Cause of Chronic Disease  500
Walter Gilbert: Selected Works 500
An Annotated Checklist of Dinosaur Species by Continent 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3662898
求助须知:如何正确求助?哪些是违规求助? 3223698
关于积分的说明 9752620
捐赠科研通 2933587
什么是DOI,文献DOI怎么找? 1606194
邀请新用户注册赠送积分活动 758307
科研通“疑难数据库(出版商)”最低求助积分说明 734775